Faculty Disclosures
In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.
Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:
SpeakersCari Berget, RN, MPH, CDCES: Dexcom: Speaker/Honoraria (Ongoing); Insulet: Consultant (Ongoing), Speaker/Honoraria (Ongoing)
PlannersNatalie Bellini, DNP, FNP-BC, BC-ADM, CDCES – Abbott Diabetes, Provention Bio, LifeScan Diabetes Institute, MannKind: Consultant
Cari Berget MPH, RN, CDCES – Insulet, Dexcom: Speakers Bureau; Insulet: Consultant
Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES – Novo Nordisk, Xeris Pharmaceuticals, Abbott: Speakers Bureau; Provention bio, Xeris Pharmaceuticals, Novo Nordisk, Bayer Pharmaceuticals, Sanofi: Consultant
Paulina N. Duker, MPH, BSN, RN, CDCES – MannKind Corporation: Employment (Ended) Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES – Abbott, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk: Speakers Bureau
Davida Kruger, MSN, APN-BC, BC-ADM –Novo Nordisk, Dexcom, Lilly, Cequr, Xeris, Sanofi: Speakers Bureau; Novo Nordisk, Lilly, Mannkind, Cequr, Abbott, Medtronic, Sanofi: Consultant; Abbott, Insulet, Tandem, Novo Nordisk, Betabionics: Institutional Research
Sean M. Oser, MD, MPH – Dexcom: Consultant
Tamara K. Oser, MD – Dexcom: Consultant; Insulet, Dexcom, Abbott: Grant Funding
Gary Scheiner, MS, CDCES – Xeris, Dexcom, Provention Bio: Speakers Bureau; Triple Jump, DiabeLoop, Lilly, Tandem, Medtronic, Glooko, Tidepool: Consultant
Becky Sulik, RDN, CDCES, LD – Lilly, Medtronic: Consultant; Medtronic, Insulet Corp, Tandem: Pump Trainer
Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP – Novo Nordisk: Consultant
Kristine Batty, PhD, CRNP, BC-ADB, CDCES - No financial relationships or conflicts of interest
Celia Levesque MSN, RN, FNP, CNS-BC, CDCES, BC-ADM - No financial relationships or conflicts of interest
Dana Roseman, MPH, CDCES, RDN/LDN - No financial relationships or conflicts of interest
Sara Wettergreen, PharmD, BCACP, BC-ADM - No financial relationships or conflicts of interest
Disclosure and Mitigation of Relevant Conflicts of Interest
All identified relevant conflicts of interest have been mitigated.
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.